Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LSCD102
- Development stage
- Preclinical
- Lead developer
- CliPS BnC
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Ophthalmic
01
Overview
LSCD102 is an autologous or allogeneic limbal stem cell therapy developed by CliPSBnC for the treatment of Limbal Stem Cell Deficiency (LSCD). LSCD is a condition characterized by the loss or deficiency of stem cells in the limbus, which are essential for the continuous renewal of the corneal epithelium. This deficiency leads to corneal conjunctivalization, vascularization, and scarring, resulting in significant vision loss and pain. LSCD102 aims to restore the corneal surface by replenishing the limbal stem cell population, thereby promoting corneal epithelial regeneration and improving visual transparency. The therapy typically involves the cultivation of limbal stem cells and their subsequent transplantation to the affected eye. As of the latest reports, the product is in the IND (Investigational New Drug) submission stage.
- Other names
- LSCD102-CliPSBnCLSCD-102-CliPSBnCLSCD 102-CliPSBnC
Beyond the preview
Go deeper on LSCD102.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LSCD102.